Political conspiracy theories aside, here are six things to know about the therapy following the FDA’s emergency use authorization.
On Sunday, the U.S. Food and Drug Administration announced an emergency use authorization, or “EUA,” allowing convalescent plasma therapy to be used to help treat those sick with COVID-19. As CNN reports, the FDA said “known and potential benefits of [convalescent plasma therapy] outweigh the known and potential risks of the product.”
Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company